Literature DB >> 10022800

Interactions between beta-herpesviruses and human immunodeficiency virus in vivo: evidence for increased human immunodeficiency viral load in the presence of human herpesvirus 6.

V C Emery1, M C Atkins, E F Bowen, D A Clark, M A Johnson, I M Kidd, J E McLaughlin, A N Phillips, P M Strappe, P D Griffiths.   

Abstract

In vitro, beta-herpesviruses can stimulate or inhibit HIV replication under particular circumstances. In order to investigate the effects of beta-herpesvirus infection on HIV replication and vice versa at an organ level, we determined the quantitative relationships between cytomegalovirus (CMV), human herpesviruses (HHV) 6 and 7, and HIV-1 proviral DNA using quantitative competitive PCR methods in 141 organs collected at autopsy from 11 AIDS patients. The presence of HHV-6 DNA in an organ was significantly associated with elevated HIV-1 proviral DNA (difference in HIV median loads, 1.3 log10 genomes; P = 0.004). Consistent with this, there was a trend for the presence of HIV-1 proviral DNA to be associated with an elevated HHV-6 load (0.44 log10 difference; P = 0.07). In contrast, there were no significant differences between viral loads in the combinations of either CMV or HHV-7 with HIV-1 proviral DNA load. Pairwise combinations of the beta-herpesviruses revealed that the quantity of HHV-7 was increased in the presence of HHV-6 (difference in median loads, 1.3 log10; P = 0.001) and the quantity of HHV-6 was increased in the presence of HHV-7 (difference in median loads, 0.7 log10; P=0.002). These results demonstrate that the presence of HHV-6 in an organ is significantly associated with an elevated HIV-1 proviral load and have implications for understanding HIV pathogenesis in the human host and the role that beta-herpesviruses, especially HHV-6, might play as cofactors in the HIV disease process.

Entities:  

Mesh:

Year:  1999        PMID: 10022800     DOI: 10.1002/(sici)1096-9071(199903)57:3<278::aid-jmv11>3.0.co;2-3

Source DB:  PubMed          Journal:  J Med Virol        ISSN: 0146-6615            Impact factor:   2.327


  10 in total

Review 1.  Update on human herpesvirus 6 biology, clinical features, and therapy.

Authors:  Leen De Bolle; Lieve Naesens; Erik De Clercq
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

2.  Human herpesvirus 6A infection and immunopathogenesis in humanized Rag2⁻/⁻ γc⁻/⁻ mice.

Authors:  Anne Tanner; Stephanie A Carlson; Masatoshi Nukui; Eain A Murphy; Bradford K Berges
Journal:  J Virol       Date:  2013-09-04       Impact factor: 5.103

3.  Histopathological detection of owl's eye inclusions is still specific for cytomegalovirus in the era of human herpesviruses 6 and 7.

Authors:  F M Mattes; J E McLaughlin; V C Emery; D A Clark; P D Griffiths
Journal:  J Clin Pathol       Date:  2000-08       Impact factor: 3.411

Review 4.  Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection.

Authors:  S D Lawn; S T Butera; T M Folks
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

5.  Persistent infection with primate foamy virus type 1 increases human immunodeficiency virus type 1 cell binding via a Bet-independent mechanism.

Authors:  Cecile Schiffer; Charles-Henri Lecellier; Abdelkrim Mannioui; Nathalie Felix; Elisabeth Nelson; Jacqueline Lehmann-Che; Marie-Louise Giron; Jean Claude Gluckman; Ali Saib; Bruno Canque
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

6.  Human herpesvirus 6A accelerates AIDS progression in macaques.

Authors:  Paolo Lusso; Richard W Crowley; Mauro S Malnati; Clelia Di Serio; Maurilio Ponzoni; Angelique Biancotto; Phillip D Markham; Robert C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-14       Impact factor: 11.205

Review 7.  Chromosomally integrated human herpesvirus 6: questions and answers.

Authors:  Philip E Pellett; Dharam V Ablashi; Peter F Ambros; Henri Agut; Mary T Caserta; Vincent Descamps; Louis Flamand; Agnès Gautheret-Dejean; Caroline B Hall; Rammurti T Kamble; Uwe Kuehl; Dirk Lassner; Irmeli Lautenschlager; Kristin S Loomis; Mario Luppi; Paolo Lusso; Peter G Medveczky; Jose G Montoya; Yasuko Mori; Masao Ogata; Joshua C Pritchett; Sylvie Rogez; Edward Seto; Katherine N Ward; Tetsushi Yoshikawa; Raymund R Razonable
Journal:  Rev Med Virol       Date:  2011-11-04       Impact factor: 6.989

8.  Viral Load Monitoring in HIV Infection.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  1999-12       Impact factor: 3.663

9.  Impact of porcine cytomegalovirus on long-term orthotopic cardiac xenotransplant survival.

Authors:  Joachim Denner; Matthias Längin; Bruno Reichart; Luise Krüger; Uwe Fiebig; Maren Mokelke; Julia Radan; Tanja Mayr; Anastasia Milusev; Fabian Luther; Nicoletta Sorvillo; Robert Rieben; Paolo Brenner; Christoph Walz; Eckhard Wolf; Berit Roshani; Christiane Stahl-Hennig; Jan-Michael Abicht
Journal:  Sci Rep       Date:  2020-10-16       Impact factor: 4.379

10.  EBV and HHV-6 Circulating Subtypes in People Living with HIV in Burkina Faso, Impact on CD4 T cell count and HIV Viral Load.

Authors:  Lassina Traore; Ouéogo Nikiema; Abdoul Karim Ouattara; Tegwindé Rébéca Compaore; Serge Théophile Soubeiga; Birama Diarra; Dorcas Obiri-Yeboah; Pegdwendé Abel Sorgho; Florencia Wendkuuni Djigma; Cyrille Bisseye; Albert Théophane Yonli; Jacques Simpore
Journal:  Mediterr J Hematol Infect Dis       Date:  2017-09-01       Impact factor: 2.576

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.